Alerts will be sent to your verified email
Verify EmailUNICHEMLAB
Unichem Lab
|
Orchid Pharma
|
Gufic Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
41.0 . | n/a | n/a |
Number of ANDA's Approved By USFDA
|
27.0 . | n/a | n/a |
R&D as a % of Total Sales
|
5.35 % | n/a | 1.28 % |
Financials
|
|||
5 yr Average ROE
|
-0.79 % | 0.86 % | 25.05 % |
5yr average Equity Multiplier
|
1.32 | 1.61 | 2.22 |
5yr Average Asset Turnover Ratio
|
0.47 | 0.5 | 1.05 |
5yr Avg Net Profit Margin
|
-1.68 % | 0.56 % | 10.9 % |
Price to Book
|
1.44 | 3.16 | 6.16 |
P/E
|
27.06 | 46.93 | 59.89 |
5yr Avg Cash Conversion Cycle
|
88.84 Days | 52.03 Days | 26.94 Days |
Inventory Days
|
151.32 Days | 112.47 Days | 66.86 Days |
Days Receivable
|
122.86 Days | 86.58 Days | 128.09 Days |
Days Payable
|
205.05 Days | 159.29 Days | 163.91 Days |
5yr Average Interest Coverage Ratio
|
2.41 | 3.01 | 13.1 |
5yr Avg ROCE
|
1.04 % | 3.08 % | 27.25 % |
5yr Avg Operating Profit Margin
|
5.43 % | 11.84 % | 18.45 % |
5 yr average Debt to Equity
|
0.11 | 0.37 | 0.51 |
5yr CAGR Net Profit
|
32.0 % | n/a | 14.26 % |
5yr Average Return on Assets
|
-0.65 % | 1.2 % | 11.52 % |
Shareholdings
|
|||
Promoter Holding
|
70.22 % | 69.84 % | 72.52 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
19.29 % | -20.12 % | -2.48 % |
Change in Mutual Fund Holding (3 Yrs)
|
1.31 % | 16.13 % | 2.35 % |
Unichem Lab
|
Orchid Pharma
|
Gufic Biosciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|